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Bacterial and viral meningitis are public health concerns as they are contagious and 
highly fatal without treatment.  Newborn infants are at high risk for bacterial and viral 
meningitis.  The onset of the infection is rapid and without quick diagnosis and treatment, many 
infants will die.  Diagnosis requires the positive identification of the causative agent through 
culture or the use of polymerase chain reaction (PCR) from specimens of cerebrospinal fluid 
(CSF).  Because these tests can take hours or days to perform, it is important identify children 
who have a higher likelihood of serious bacterial or viral infection so that empiric therapy can be 
initiated while awaiting further results.  Previous studies have indicated that CSF characteristics 
can be accurate early predictors of viral and bacterial meningitis.  Although CSF characteristics 
have been established for infection, normal values for infants less than 60 days of age are still not 
clear. To improve characterization of CSF values for infants, this study set to answer three 
questions:  Is there a temporal relationship for CSF WBC, glucose, and protein?  What are the 
means and confidence intervals for the means for each of these variables?  What is the range of 
normal values that a physician could expect to find in infants less than two months of age?  This 
study involved three independent retrospective chart reviews over a 15-year period to identify 
infants less than two months of age who presented to The Children’s Hospital of Pittsburgh 
emergency department with fever and had lumbar punctures performed but were not found to 
have bacterial or viral meningitis.  For CSF WBC and protein, the data from the three cohorts 
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were pooled and a single set of reference values was generated for infants less than two months 
of age.  CSF glucose values were not pooled due to differences that existed between the cohorts 
and reference values were calculated for the cohorts individually.  CSF white blood cell (WBC), 
glucose, and protein values were analyzed to answer our three study objectives. A temporal trend 
was found for CSF WBC and protein with values being highest during the first weeks of life.   
CSF glucose values did not change with time.  These values will be potentially valuable 
reference tools in emergency departments for physicians who are faced with decisions regarding 
care and treatment of febrile infants. 
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1.0  INTRODUCTION 
1.1 DESCRIPTION OF THE PROBLEM 
Lumbar puncture has long been the standard of care for infants less than 60 days of age who 
present with fever in emergency departments1.  Although the procedure has its risks, it is the best 
way to determine whether the infant has meningitis.  Administering antibiotics without 
performing a lumbar puncture can lead to complications, delaying diagnosis of bacterial 
meningitis and can make analyzing cerebrospinal fluid (CSF) diagnostic values difficult2.    
Bacterial and viral meningitis, which are inflammation of the meninges caused by bacteria or 
virus, respectively, have very high mortality rates in babies - as high as 20%3.  Early 
identification of meningitis can result in better outcomes by leading to earlier treatment of the 
infection and better management of the infant.  Currently, significant amounts of time are 
required to complete bacterial and viral cultures and other diagnostic tests on the CSF.  
Therefore, a rapid predictor of meningitis is needed to help accelerate the process of identifying 
infants who are in need of treatment.  In 1989, Spanos et al. made the observation that the initial 
values of the CSF, including glucose, protein, and white blood cell (WBC) levels, can be good 
predictors of disease outcome4.  Although no single factor was able to predict whether or not an 
infant will test positive for infectious meningitis, the three taken together were able to predict 
99% of cases of infection.4,5  Although in general there are certain values for CSF WBC, 
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glucose, and protein which are more likely to be associated with bacterial and viral meningitis, it 
is uncertain just how high or how low these values need to be to warrant action or empiric 
therapy.  In other words, values for normal infants without meningitis need to be determined in 
order to better direct treatment.  Despite previous studies attempting to identify the CSF 
characteristics of healthy infants, no study yet has incorporated stringent enough inclusion 
criteria, included a substantial number of infants for analysis, or has stratified infants in 
appropriate age categories to provide values that have clinical relevance. This study fills this 
void in the literature by including infants less than eight weeks of age who were not born 
prematurely, had no previous history of seizure, did not have a traumatic lumbar puncture (LP; 
>1000 red blood cells [RBCs] /mm3), and had negative blood, urine, and CSF cultures for 
microorganisms.  Our hypothesis for this study is that significant variation exists within CSF 
WBC, glucose, and protein for infants depending on age by week.  Specifically, we want to 
answer three objectives:  Does a significant temporal trend exist for these variables, what are the 
means and confidence intervals for CSF WBC, glucose, and protein, and what is the expected 
range of values for these variables.   These reference values will serve as a potentially valuable 
predictive tool for physicians treating febrile infants with suspected meningitis before CSF 
culture and diagnostic tests can be completed.  
1.2 CEREBROSPINAL FLUID 
CSF is a clear, colorless fluid that is primarily made in the choroid plexus in the lateral ventricles 
by modified ependymal cells6.  These cells do not passively or actively transport CSF following 
its production,  rather they secrete it after it is made.  Following the filtration of blood that is the 
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precursor of CSF, the CSF is secreted into the lateral ventricles of the brain6,7.  Following its 
production in the choroid plexus, the CSF flows through the interventricular foramen of Munro 
to the third ventricle.  From there, it flows to the fourth ventricle and through the foramen of 
Luschka and Magendie to reach the subarachnoid spaces.7  The anatomical locations and 
pathways of CSF flow can be seen in Figure 1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  Pathways of the Formation of the Cerebrospinal Fluid6. 
Copyright Permissions Granted. 
 
The subarachnoid space, the region between the pia mater and the arachnoid mater, 
surrounds the brain, ventricles, and spinal cord6,7.  The subarachnoid spaces and the ventricles 
contain approximately 140 mL of CSF, and it is estimated that it is remade every five to seven 
hours.  This constant renewal allows for a lumbar puncture to provide an accurate “snapshot” of 
what is present in the CSF in terms of cell counts, glucose, and protein levels.   
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The CSF serves many physiologically significant roles.  Primarily, its role is to provide a 
cushion for the brain – it provides buoyancy and reduces the weight of the brain by nearly 
95%6,7.  The CSF is a sterile fluid and has limited access to cells, proteins, and metabolites.  This 
limited access is maintained by the “blood-brain barrier”, which is the system that screens the 
particles that are allowed access to the brain.  The blood-brain barrier is important not only for 
necessary metabolites but also for access of cells in normal and pathological situations.  The 
choroid plexus is largely made up of blood vessels and specialized endothelial cells.  The barrier 
between these cells and the subarachnoid space is called the brain-CSF barrier.  It is a secondary 
barrier to the blood-brain barrier, and also functions in preventing access of blood metabolites 
and cells to the CSF8.  Superficially, the ependymal cells appear like cells in the small intestine, 
which are arranged in villi and designed for absorption.  A picture of these specialized cells can 
be seen in Figure 2.   
 
 
 
 
 
 
 
 
 
Figure 2:  Epdendymal Cells are Responsible for the Formation of CSF7. 
Copyright Permissions Granted. 
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The blood-brain barrier is composed of the capillaries in the brain and the astrocytes, 
specialized support cells in the brain.  The endothelial cells that make up the capillaries in the 
brain are different from those seen in other blood vessels, however.  They form tight junctions 
and are bound tightly by astrocytes.  A picture of the blood brain barrier can be seen in Figure 3. 
 
Figure 3:  The Blood-Brain Barrier is Composed of Endothelial Cells and Astrocytes9. 
Copyright Permissions Granted. 
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Besides having tight junctions, the endothelial cells in the brain capillaries also differ 
from other endothelial cells based on their cellular machinery.  “Intracellular clefts, pinocytotic 
vesicles, and fenestrae, which readily allow for transcapillary exchange in most systemic 
capillaries, are virtually not seen in normal brain endothelial cells”10.  It is thought that this lack 
of machinery is what accounts for the exclusivity of the blood-brain barrier. A comparison of 
general endothelial cell transport and brain endothelial cell transport mechanisms can be seen in 
Figure  4.  
 
 
Figure 4: A Comparison of the Mechanisms of Transport between General Endothelial Cells (right) 
and Brain Endothelial Cells (left)8.   
Copyright Permissions Granted. 
 
For most macromolecules, their movement across the blood-brain barrier depends on 
their molecular weight.  The smaller the molecular, the more likely it will be able gain access to 
the brain. Regulation of glucose concentration in the CSF is dependent upon facilitated diffusion,  
while protein transfer is dependent upon ultrafiltration, diffusion (if the proteins are small 
enough), or pinocytosis (for larger proteins)7.  The majority of cells and larger particles (such as 
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bacteria) are prevented from reaching the brain by the intricate placement of tight junctions 
between astrocytes and endothelial cells that compose the blood brain barrier7,10.   
There are times during development that the blood brain barrier does not have such 
stringent passage restraints.  During infancy, the blood brain barrier has been found to be more 
permeable than later in life. Although it is not certain why this increased permeability exists, it 
may be due to the “immaturity” of the junctions between the endothelial cells and astrocytes.  
This can allow for more migration of cells and proteins from the blood into the CSF following 
birth.  It is also possible that the “trauma” experienced during birth can cause some inflammation 
to the meninges, which additionally allows for more transport of molecules that are normally not 
present in the adult CSF.10-14   It is assumed that glucose levels are higher in the first months of 
life because of the immaturity of the glucose exchange mechanisms7.  Regardless of the cause, 
CSF characteristically has more white blood cells (WBCs), protein, and glucose during the first 
two months of life as compared to babies older than two months, children, and adults.  These 
differences in CSF composition appear to decrease after about eight weeks of life, after which 
the CSF constituents begin to approach levels that are experienced during times of  normal adult 
health10.   
The relative exclusivity of the blood brain barrier can also be affected by infection. 
Meningitis, generically defined as the inflammation of the meninges, can lead to increased 
permeability in the barrier.  This increased permeability allows white blood cells, high molecular 
weight proteins, and other macromolecules to move more easily across the blood brain barrier 
and into the CSF.  One of the classic signs of meningitis is pleocytosis –  an increased WBC 
count in the CSF.   In both bacterial and viral meningitis, pleocytosis and increased protein are  
present, although to varying degrees.   Glucose concentrations, however, do not follow the same 
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pattern in bacterial and viral meningitis15.   During bacterial meningitis,  CSF glucose levels are 
lower than in normal homeostasis10.  Although the reasons for this are not clear, it is suggested 
that as more cells and larger macromolecules enter the CSF, the ependymal, endothelial and 
migratory cells need more energy and thus perform greater amounts of glycolysis. Additionally, 
if the meningitis is caused by bacteria, the presence of bacteria in the meninges and the CSF can 
also account for a decrease in glucose.  The combination of these factors may account for the 
reduction in normal levels of glucose during a bacterial infection in infants, children, and 
adults.10  During viral meningitis, however, glucose levels the same or higher than normal.  This 
could be because viruses do not require the use of supplementary glucose.  Additionally, because 
WBC levels are not as high in viral meningitis as compared to bacterial meningitis, there are not 
as many cells requiring glucose.  Despite these observations, the exact mechanisms and signaling 
pathways that lead to increased and decreased glucose transport during different types of 
meningitis are still largely not understood.   A summary of these characteristic trends is seen in 
Table 1.  
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Table 1: Typical CSF Findings in Infectious Meningitis15.  
 Copyright Permissions Granted. 
Cause of 
meningitis 
White blood cell 
count  (cells/mm3) 
Predominant cell type CSF:serum 
glucose  
(normal 0.5) 
Protein (g/l) 
(normal 0.2-
0.4) 
Viral 50-1000 Mononuclear (may be 
neutrophilic early in 
course) 
>0.5 0.4-0.8 
Bacterial 100-5000 Neutrophilic 
(mononuclear after 
antibiotics) 
<0.5 0.5-2.0 
Tuberculous 50-300 Mononuclear <0.3 0.5-3.0 
Cryptococcal 20-500 Mononuclear <0.5 0.5-3.0 
 
Meningitis has many different causes, both infectious and non-infectious.  The causes of 
infectious meningitis will be considered in the next section. 
 
1.3 MENINGITIS DUE TO INFECTION 
In general, meningitis is a generic term which refers to inflammation of the brain and spinal 
cord’s coverings – the meninges.  The brain and spinal cord are surrounded by three meninges – 
the closest to the brain is the pia mater, the central covering is the arachnoid mater, and the outer 
is the dura mater.  A picture of the relation between the three meninges can be seen in Figure 5.  
The pia mater is a thin connective tissue membrane that closely surrounds the brain and spinal 
cord.   The arachnoid mater surrounds the brain more loosely and also extends along the roots of 
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cranial and spinal nerves.  The dura mater is the tough outer covering that is attached firmly to 
the inside of the skull.7   
 
 
 
Figure 5:  The meninges of the brain and spinal cord16. 
Copyright Permissions Granted 
 
The causes of meningitis are numerous and include trauma, complications from drug use, 
bacterial infections, viral infections, and fungal infections17.  The majority of causes of 
meningitis are due to bacteria and viruses.  For this study the following definitions will be used: 
- Proven bacterial meningitis:  positive CSF bacterial culture 
- Viral meningitis:  positive CSF viral culture or PCR test 
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- Presumed bacterial meningitis:  CSF pleocytosis with a positive blood culture, and a 
negative CSF culture 
The causes and rates of death of bacterial and viral meningitis vary in populations 
depending on the age of the patient.  In neonates and infants, the rate of bacterial and viral 
meningitis is between two and 10 per 100,000 live births18.  This rate is higher than at any other 
time in a person’s life.   The fatality rate of meningitis also varies due to the causative agent and 
the child’s age.  It has been postulated that without effective treatment the death rate can 
approach 100%3.  In infants who receive treatment, however, the death rates are approximately 
20%.3,18   Even in children who survive, about 15% of these have long-term effects from the 
infections including deafness, seizures, learning disabilities, and lower intelligence.  
The major causes of bacterial meningitis in young infants are Group B Streptococcus, 
Haemophilus influenza type B, Listeria monocytogenes, Escherichia coli, Streptococcus 
pneumonia, and Neisseria meningitidis3,18.  In developed countries, the rates of meningitis due to 
Group B Streptococcus and H. influenza have decreased dramatically since the introduction of 
vaccines19.  The majority of newborn bacterial meningitis is transmitted vertically, often through 
direct contact with or inhalation of bacterial strains present in the mother’s vaginal and intestinal 
tracts.   Bacterial meningitis in infants is often a result of septicemia. Although septicemia is 
uncommon in infants, only 1 to 8 per 1,000 live births, the rate of bacterial meningitis as a result 
of septicemia is 25%3.  
Viral meningitis and aseptic meningitis are terms that are sometimes used 
interchangeably, although aseptic meningitis is a more general term that implies that the 
symptoms of meningitis are present although no bacteria can be isolated from CSF or blood 
cultures3.  Frequently, aseptic meningitis is caused by viruses.  Tests for diagnosing meningitis 
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caused by viruses have advanced significantly, and polymerase chain reaction (PCR) assays are 
now available for the rapid diagnosis of many viral pathogens.  In infants, the most common 
causes of viral meningitis are enteroviruses, Epstein-Barr Virus, Varicella-Zoster Virus, mumps 
virus, herpes simplex virus, and human immunodeficiency virus (HIV) 3,15.  The major causes of 
bacterial and viral meningitis are summarized in Table 2.   
Table 2:  The Common Causes of Infectious Meningitis in Infants. 
Common Causes of Infectious Meningitis in Infants 
Bacterial Viral 
Group B Streptococcus Enterovirus 
Streptococcus pneumoniae Epstein-Barr Virus 
Haemophilus influenza type B Varicella-Zoster Virus 
Neisseria meningitidis Mumps Virus 
Listeria monocytogenes Herpes Simplex Virus 
Escherichia coli Human Immunodeficiency Virus (HIV) 
 
The clinical manifestations of meningitis are a sore or stiff neck, fever, headache, the 
inability to tolerate bright lights or noises, and in some cases, a rash on the torso18.  In adult 
populations, symptoms of meningitis are easier to detect because the patient is able to tell the 
physician what is causing discomfort.  In infants, however, most physicians have to rely on the 
parents’ observations.  Fever, irritability, and not wanting to feed are the most common 
symptoms of meningitis in infants3.  These non-specific symptoms make clinical assessment 
difficult. The physician has to decide whether to perform a lumbar puncture, the diagnostic test 
for confirming meningitis.  However, because of the relatively high rates of meningitis in infants, 
physicians are often inclined to perform a lumbar puncture and collect CSF to err on the side of 
caution.   
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1.4 LUMBAR PUNCTURE IN INFANTS 
As previously stated, lumbar puncture is a common diagnostic tool in the identification of 
bacterial and viral meningitis.  The procedure, although painful for the infant and not without 
risk of compliciations, is often necessary.  Although there has been some debate as to whether  
this procedure should be common in the evaluation of febrile infants, a retrospective study done 
by Visser and Hall found that the removal of lumbar puncture from emergency workups would 
have led to 15% of cases of meningitis missed in febrile infants.1,20   
Lumbar puncture involves using a needle that is inserted into the subarachnoid space of 
the spinal cord to collect cerebrospinal fluid (CSF).  The overall procedure is similar to the one 
performed in adults but there are some key precautionary differences when performing a lumbar 
puncture on an infant.  Primarily, the positioning of a baby differs from the positioning of an 
adult and is very important to ensure a safe and sufficient collection of fluid.  Adults and older 
children undergoing the procedure are advised to position themselves in the fetal position.  
Infants, however, should be positioned so that their legs are perpendicular to the rest of the body 
and the back is slightly curved1.  This positioning can be seen in Figure 6. 
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This position opens the spaces between the lumbar vertebrae and allows for the easiest 
access of the needle1.  In most cases, the needle is inserted between the L3/L4 or the L4/L5 
vertebrae.  A ‘pop’ may be felt when the needle penetrates the dura and arachnoid mater and 
enters the subarachnoid space.  However, this ‘pop’ should not be depended upon in infants, as it 
may be very subtle or absent1.  The final positioning of the needle in the subarachnoid space can 
be seen in Figure 7.  
Figure 6: The Proper Positioning of an Infant for Lumbar Puncture1. 
Copyright Permissions Granted. 
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Figure 7: The Proper Positioning of the Needle when Performing a Lumbar Puncture1 
Copyright Permissions Granted. 
 
 
When performing a lumbar puncture, the clinician must be careful not to overshoot the 
subarachnoid space and enter the underlying tissue.  This can cause a bleed into the CSF, which 
is more commonly referred to as a traumatic lumbar puncture. Quantitatively, a traumatic lumbar 
puncture is defined as being >1000 red blood cells (RBCs)/mm3 of CSF.   Because of the 
difficulties in performing a lumbar puncture in infants, approximately 20% of these procedures 
result in a traumatic lumbar puncture1.  Besides providing discomfort to the infant, a traumatic 
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lumbar puncture introduces components into the CSF that can obscure the analysis.  Although 
formulas have been developed to help “correct” for WBC counts in cases of traumatic lumbar 
puncture, no such formulas have been developed to help correct for glucose and protein 
concentrations.   
In order to perform all of the necessary analyses on the CSF, a minimum of 3mL of fluid 
must be collected from a lumbar puncture.  In general, tests must be performed within 30 
minutes following collection or the cells present in the CSF will begin to lyse. A drop of CSF is 
needed to determine total WBC and RBC counts by using a Fuchs-Rosenthal counting 
chamber21.  Samples are also used to determine the CSF protein and glucose concentrations 
using reagent strips similar to those used to measure protein and glucose levels in the blood or 
urine.  If a differential count of the cells is desired, the CSF is centrifuged and then a Wright 
stain is applied to characterize the different distribution of white blood cells21.  A Gram stain to 
check for the presence of bacteria is also commonly performed and, although this stain can be 
definitive, its success is dependent on the number of bacteria present in the CSF.  Concentrations 
of  ≤103 colony forming units(cfu)/mL will only give a positive gram stain 25% of the time,  
concentrations between 103 and 105 cfu/mL give a positive gram stain 65% of the time, and 
concentrations >105 cfu/mL give a positive gram stain 97% of the time22.   In addition, besides 
the concentration of bacteria present in a sample, the causative agent itself can also influence the 
success of identifying the presence of infection using a gram stain.  As long as the colony 
forming unit criteria are met, 90% of cases caused by Streptococcus pneumonia, 86% of cases 
caused by Haemophilus influenza, 76% of cases caused by Neisseria meningitides, 50% of cases 
caused by gram-negative enteric bacilli, and 33% of cases caused by Listeria monocytogenes can 
be identified from gram stain results22.   Because of these reasons, it is very important to perform 
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cultures and other diagnostic tests in addition to the initial descriptive analyses previously 
discussed.   
Besides these rapid tests, additional tests should be done on the CSF to confirm the 
presence of an infection.  The CSF should be cultured and tested for a variety of bacterial and 
viral pathogens.  Standard culture technique for bacteria involves using a 5% blood agar, 
chocolate agar, and enrichment broth23.  The 5% blood agar and chocolate agar plates serve to 
isolate true pathogens causing bacterial meningitis, whereas the enrichment broth serves as a 
control.  Streptococcus pneumonia and Listeria monocytogenes will be able to grow on the 5% 
blood agar.  Chocolate agar is used for the isolation of Haemophilus influenza and Neisseria 
meningitides. If there is growth in the broth but not on the plates, it is likely that the growth seen 
in the broth is not a true pathogen and is indicative of human error or contamination from the 
skin23.  For culturing viruses, the frequently used standard are cultures using human diploid 
fibroblasts, primary monkey kidney, Buffalo monkey kidney, and rhabdomyosarcoma cell 
lines14. The use of several cell lines ensures isolation of a wide variety of viruses, including 
enteroviruses, herpes simplex I and II, and mumps virus14.  In the case of viral pathogens, PCR 
tests have been developed for the CSF to accurately confirm the presence of infection.  These 
tests are far more accurate than the viral cultures that were commonplace in the past15. Currently, 
PCR testing is available for enteroviruses and herpes simplex viruses at the Children’s Hospital 
of Pittsburgh. A summary of these procedures and other PCR tests can be seen in Table 3.    
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Table 3:   Diagnostic Tests for Viral Meningitis15.   
Copyright Permissions Granted. 
Cause Key diagnostic test Other potentially useful tests 
Enteroviruses CSF PCR Throat and rectal swabs—culture, PCR  
Herpes Simplex 
Virus (HSV) 
CSF PCR HSV type specific serology. Detection in genital 
lesions—PCR, culture, immunofluorescence, 
electron microscopy, Tzanck smear 
Varicella Zoster 
Virus 
CSF PCR Detection in skin lesions—PCR, culture, 
immunofluorescence, electron microscopy, Tzanck 
smear 
HIV Serology Serial IgG or combined IgG and antigen tests—HIV 
viral load (plasma, CSF) 
Mumps Virus Serology (serum, oral 
fluid) 
PCR (throat swab, urine, EDTA blood, oral fluid) 
Epstein-Barr 
Virus (EBV) 
EBV specific serology, 
VCA IgM and IgG, 
EBNA IgG 
CSF PCR. Monospot test 
EBNA=Epstein-Barr nuclear antigen; PCR=polymerase chain reaction; VCA=viral capsule 
antigen; EDTA=ethylenediaminetetraacetic acid. 
 
These tests offer an advantage over traditional culture methods because they are often 
more sensitive as well as quicker than the incubation times necessary for bacteria to grow, and 
because PCR tests exist for viruses as well as bacteria.  PCR primers for most of the common 
bacterial pathogens also exist and can be used in addition with viral PCR to simultaneously test 
for viruses and bacteria23. 
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1.5 REVIEW OF PREVIOUS STUDIES 
Numerous studies have attempted to analyze CSF diagnostic values in healthy newborns.  A 
summary of the authors, year the study was conducted, study population, and major findings can 
be seen in Table 4.  A further description of these studies follows. 
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Table 4:  A Summary of the Major Studies Involving the Analysis of CSF Constituents5,11-14,24,25. 
Author Year Population Age 
Groupings/ 
Strata 
CSF WBC 
(cells/mm3) 
CSF 
Glucose 
(mg/100mL) 
CSF 
Protein 
(mg/100mL) 
Samson11 1931 Infants < 6 
months 
0-2 weeks 
2 wks-3mo 
3-6 mo 
3.33 
3.00 
1.33 
 
No data 60.0 
32.0 
24.0 
Widell11 1958 48 children 
<2 months 
0-6 days 
7-13 days 
14-27 days 
28-41 days 
42-59 days 
7.50 (avg for 
all groups) 
No Data 80.9 
70.4 
53.9 
46.5 
34.8 
Naidoo12 1968 135 infants 
< 24 hours 
 Polymorphs:  
3.00 
Lymphocytes: 
2.00 
51.0 63.0 
Sarff et 
al.5 
1976 117 infants Term 
Preterm 
8.20 
9.00 
81.0 
74.0 
90.0 
115.0 
Pappu et 
al.24 
1982 24 infants < 
32 days 
 11.00 No data 32.0-80.0 
Portnoy 
and 
Olson25 
1985 371 infants 
and 
children, 
birth to 10 
years 
< 6 weeks 
6 wks-3mo 
3-6 mo 
6-12 mo 
>12 mo 
3.37  
2.92  
1.88  
2.63  
1.94  
 
No Data No Data 
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Table 4:  Continued 
Author Year Population Age 
Groupings/ 
Strata 
CSF WBC 
(cells/mm3) 
CSF 
Glucose 
(mg/100mL) 
CSF 
Protein 
(mg/100mL) 
Bonadio 
et al.21 
1992 75 infants < 
8 weeks 
0-4 weeks 
4-8 weeks 
11.00 
7.10 
46.0 
46.0 
84.0 
59.0 
Ahmed et 
al.14 
1996 108 infants 
< 30 days 
1 week 
2 week 
3 week 
4 week 
15.30 
5.40 
7.70 
4.80 
45.9 
54.3 
46.8 
54.1 
80.8 
69.0 
59.8 
54.1 
 
 
One of the first studies performed to examine the normal values of the CSF was 
published in 1931 by Samson. He investigated the WBC and protein levels in infants ages 0-2 
weeks, 2 weeks-3 months, and 3-6 months11.  Samson did not include the total number of infants 
studied; therefore it is uncertain what inclusion criteria he used.  The results from Samson’s work 
can be seen in Table 5.  Samson’s major contribution to the field was that he found that children 
ages 6 months and older have similar WBC counts as adults11.    
 
Table 5:  Samson’s Study of the Cerebrospinal Fluid in Infants11. 
Age CSF WBC count (mean) CSF Protein (mean) 
0-2 weeks 3.33 cells/mm3 60.0 mg/100mL 
2 weeks – 3 months 3.00 cells/mm3 32.0 mg/100mL 
3-6 months 1.33cell/mm3 24.0 mg/100mL 
 
The next significant study was done by Widell in 1958.  Widell also examined the CSF 
WBC and protein levels in infants.  This study looked at 48 children under 1 year of age.  No 
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children were included who had fever or any symptoms of central nervous system disease.  All 
of the children had a lumbar puncture done between the second and third lumbar vertebrae11. 
According to the results, the greatest number of RBC in any of the punctures was 675 cells/mm3, 
so this infers that none of the punctures was considered traumatic.  Widell’s study found that the 
number of WBCs in the CSF was elevated during the first three months of life, especially within 
the first two weeks, compared to the latter nine.  The exact numerical results for results for the 
CSF WBC counts are not given by age in weeks, although it is stated that within the first two 
weeks of life, the number of CSF WBCs varied between 0 and 15 cells/mm3, with a mean of 7.5 
cells/mm3 11.  Widell’s graph of CSF WBCs by age can be seen in Figure 8. 
 
 
Figure 8:  Widell’s Investigation of CSF WBC in Infants During the First Year of Life11. 
Copyright Permissions Granted. 
 
The protein levels were also seen be greater within the first three months of life as 
compared to the latter nine11.  The figure from Widell’s manuscript can be seen in Figure 9.   
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Figure 9: Widell’s Distribution of Protein per 100mL of CSF11. 
Copyright Permissions Granted. 
 
Table 6 summarizes the protein levels found by Widell for infants ages 0-6 days, 7-13 
days, 14-27 days, 28-41 days, and 42-59 days. 
 
Table 6:  Widell’s Study of Protein Levels in the CSF11. 
Age Total Protein (mg/100mL) 
0-6 days 80.9 
7-13 days 70.4 
14-27 days 53.9 
28-41 days 46.5 
42-59 days 34.8 
 
Widell’s study was followed in 1968 by Naidoo.  In this study, Naidoo examined 135 
newborn infants within the first 24 hours of life who were born at King Edward VII Hospital in 
Durban, South Africa.  All healthy babies were included, and any who had “any obvious 
pathology were excluded from the study”12.  Naidoo seems to have performed all the lumbar 
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punctures himself and he chose to perform the procedure with the children in a sitting position 
and by inserting the needle between the first and second lumbar space.  A subgroup of 20 infants 
had repeat lumbar punctures performed at seven days of age to compare the newborn values with 
infants one week of age.  Naidoo does not provide his results for WBC alone.  Rather, he 
stratifies the results by polymorphonuclear cells and lymphocytes.  The results of Naidoo’s 
studies are seen in Table 7 for infants 1 day old and in Table 8 comparing 1 day olds and 7 day 
olds. 
 
Table 7: Naidoo’s Examination of  CSF values within the first 24 hours of life12. 
Characteristic Range Mean 2 Standard 
Deviations 
Red Blood Cells  
(cells/mm3) 
0-1070 9.00 0-884.00 
Polymorphs 
(cells/mm3) 
0-70.00 3.00 0-27.00 
Lymphocytes 
(cells/mm3) 
0-20.00 2.00 0-24.00 
Proteins 
(mg/100mL) 
32-240.00 63.0 27.0 - 144.0 
Sugar  
(mg/100mL) 
32-78.00 51.0 35.0 - 64.0 
 
 
 
 
 
 
 25 
Table 8:  Naidoo’s Comparison of 20 Infants on Day 1 of Life and Day 7 of Life12. 
 Day 1 Day 7 
Characteristc Range Mean Range Mean 
Red Blood Cells 
(cells/mm3) 
0-620.00 23.00 0-48.00 3.00 
Polymorphs 
(cells/mm3) 
0-26.00 7.00 0-5.00 2.00 
Lymphocytes 
(cells/mm3) 
0-16.00 5.00 0-4.00 1.00 
Protein 
(mg/100mL) 
40.0 - 148.0 73.0 27.0 – 65.0 47.0 
Sugar 
(mg/100mL) 
38.0 – 64.0 48.0 48.0 – 62.0 55.0 
 
 
From Table 7, we can see that Naidoo did not exclude infants who had traumatic lumbar 
puncture.   We can also see that the ranges for newborn infants are highly variable.  Naidoo’s 
data show that within seven days, the WBC and protein levels drop drastically, from 12 total 
cells/mm3 to 3 cells/mm3 for CSF WBC counts and from 73 mg/100mL to 47mg/100mL of 
protein.  Glucose, however, remains nearly constant, at 48mg/100mL at age 1 day to 55 
mg/100mL at age 7 days.   Finally, Naidoo concludes, comparing his data to a cohort of infants 
ages 3 months to 1 year of age, that CSF values reach “normal” adult levels at age 3 months.12  
Besides Naidoo’s inclusion of infants with traumatic lumbar punctures, his study is a solid study 
of infants ages 0-7 days.  He does not consider infants any older than one week of age, however, 
even though he states that values approach “normal” values within 3 months of life. This study 
would have been more significant to the field if he had included more infants or continued 
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testing infants by week of age to get an accurate idea of the transitions of CSF WBC, protein, 
and glucose levels from birth to  CSF “adulthood”.   
In 1976, Sarff et al. examined the differences between CSF in high risk infants with and 
without meningitis.  For this study, 132 neonates born at Parkland Memorial Hospital in Dallas, 
Texas were included.  These infants had lumbar punctures performed because they were at “high 
risk” for developing meningitis.  Sarff et al. defined “high risk” as “unexplained jaundice, 
prematurity, prolonged rupture of membranes, chorioamionities, abruption placenta, maternal 
fever, and toxemia”5.  The majority of the eligible infants were less than seven days old 
(100/117).  The infants were divided into two groups – term and preterm, and then their CSF was 
analyzed for WBC count, protein, and glucose.  The results for term vs. preterm infants can be 
seen in Table 9. 
 
Table 9:  Sarff et al.’s Comparison of High Risk Term and Preterm Infants5. 
Characteristic Term  
N=87 
Preterm 
N=30 
White Blood Cells 
(cells/mm3) 
Mean 
2 Standard Deviations 
 
 
8.20 
0-22.40 
 
 
9.00 
0-25.4 
Protein (mg/100mL) 
Mean 
 
90.0 
 
115.0 
 
Glucose (mg/100mL) 
Mean 
 
81.0 
 
74.0 
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Sarff et al. found that for preterm infants there was a significant positive correlation of 
the WBC count values increasing throughout the first week of life.  For term infants, however, 
there was no such correlation and levels tended to drop, although not to a significant level.5  
Although Sarff et al. state that they removed infants who had undergone a traumatic lumbar 
puncture, they state that the range of RBC in the CSF ranged from 0-46,000 cells/mm3 in term 
infants and 0-39,000 cells/mm3 for preterm infants.  These values clearly show that infants who 
suffered a traumatic lumbar puncture were included in the analysis.    As for protein and glucose, 
Sarff et al. state that there were no significant differences between these values between term and 
preterm infants5.   Importantly, Sarff et al. also compared their values for “normal’ neonates to a 
cohort of 119 infants with bacterial meningitis.  They found that although there was some 
overlap between individual values, not one child with meningitis fell into the category of having 
“normal” values for CSF WBC, glucose, and protein levels5.  This finding reinforces the idea 
that using these criteria as a predictor for meningitis can be beneficial, as long as all values are 
taken into consideration.   
In 1982 Pappu et al. expanded upon the work of Sarff et al. and Naidoo and explore the 
differential composition of CSF WBC early in life.  In this study, 24 normal birth weight infants 
between 1 and 32 days of age were analyzed for their CSF WBC differential.  The infants 
included in this study were admitted to the hospital for being at a high risk for the development 
of meningitis.  Infants were excluded if they had RBC counts >500cells/mm3, and had positive 
blood or CSF cultures24.  Although Pappu et al. gives a mean value for the WBC count, only a 
range is included for protein levels.   The results from the study can be seen in Table 10.   
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Table 10: Pappu et al.’s Study of 24 Normal Birth Weight Infants Ages 1 to 32 days for CSF Total WBC and 
Protein24. 
 WBC Count (cells/mm3) Protein (mg/100mL) 
Normal Birth Weight Infants 
(n= 24) 
11.00 (1.00 – 38.00) 32.0 – 80.0 
 
 
Pappu et al’s study had a relatively low number of patients and did not indicate what 
inclusion criteria were used to determine what was considered “high risk” for the development of 
meningitis.  Despite these drawbacks, it is important to note that determining accurate 
measurements of WBC count and protein for infants was not the main objective of this study.  
However, the information collected by Pappu et al. aligns well with data found previously found 
in infant populations. 
The next major study of CSF composition was a retrospective chart review conducted in 
1985 by Portnoy and Olson.  In this study, 371 infants and children were divided into five age 
categories :  < 6 weeks, 6 weeks to 3 months, 3-6 months,  6-12 months, and >12 months. The 
youngest infant was approximately 1 day old whereas the oldest child was 10.5 years old. Infants 
were included in this study if they were “sick enough  to warrant CSF examination, but who 
were found to have disease unrelated to CSF infection25”.  Infants were also included if they had 
suffered seizures prior to examination, in an attempt to determine whether infants with seizures 
require a different set of values than those without seizures.  Infants were excluded if they had 
illnesses that were attributed to CSF infections of viral or bacterial nature.  One of Portnoy’s 
aims in this study was to characterize the distribution of WBC counts among age groups. 
Therefore, the means, standard deviations, and 25th, 50th, and 75th percentiles were calculated for 
each age group.  The results can be seen in Table 11. 
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Table 11:  Portnoy and Olson’s Study on CSF Distributions Among Infants and Children25. 
Age N Mean WBC 
(cells/mm3) 
 (+/- standard 
deviation) 
25% 50% 75% 
<6 weeks 64 3.37  
(+/- 3.40) 
0.50 2.57 5.16 
6 weeks-3 
months 
67 2.92 
(+/- 2.86) 
0.34 1.86 3.75 
3-6 months 84 1.88  
(+/- 2.01) 
0.00 1.11 2.31 
6-12 months 75 2.63 
(+/- 2.45) 
0.41 1.47 3.25 
>12 months 81 1.94 
(+/- 2.72) 
0.00 0.68 1.82 
 
 
From these data, we see that the highest variability is in infants < 6 months of age.  As 
age increases, the variability in the CSF WBC values also decreases.  We also see that the 
majority of infants <3 months do not have 0 cells/µL in their CSF, whereas it is more common in 
infants/children greater than 3 months of age.25  This observation reinforces data previously 
discussed where CSF levels reached “normal” limits at between two and three months of age.  In 
addition to these data, Portnoy and Olson examined CSF values in patients without seizures and 
patients with seizures.  They found that for all age groups, there were no significant differences 
in WBC counts between patients with and without seizures25.  From their data, Portnoy and 
Olson suggest that using the cutoffs presented from their study will ensure that few 
infants/children will be missed who have actually have bacterial/viral meningitis.25  Portnoy and 
Olson’s study was very beneficial to the field because it included infants who were actually 
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presenting with symptoms similar to those seen in meningitis.  Also, it used a wide variety of age 
groups to characterize CSF values.  It is our opinion, however, that the system used by Portnoy 
and Olson should be expanded to include age stratifications within the early time points.  
Because it appears as though variability is much lower after the 3 month time point, analyzing 
data from infants by week of age will provide needed information about the variation seen within 
the first few months of life in terms of CSF composition.  Additionally, Portnoy and Olson do 
not state whether traumatic lumbar puncture was included and they do not analyze the CSF for 
glucose or protein.  These shortcomings make this study an incomplete view on the characteristic 
values of the CSF in infants.  
In 1989, Spanos et al. took a different approach to the problem of defining CSF 
characteristics.  Instead of looking at normal values of CSF, they chose to look at CSF values in 
cases of bacterial and viral meningitis in order to determine the predictive values of CSF WBC, 
protein, glucose, and CSF-blood glucose ratio.  For this study, they examined 422 patients who 
presented with bacterial or viral meningitis at Duke University Medical Center in Durham, NC 
between January 1969 and July 19804.  It is important to note that for this analysis they excluded 
all patients under 1 month of age.  Using an advanced algorithm, they found that four 
independent measurements were able accurately to predict 55 cases of bacterial meningitis and 
56 cases of viral meningitis.  These measurements were total WBC count in the CSF, glucose, 
protein, and date of onset (past August 1).4 Date of onset was taken into consideration because 
viral meningitis and some types of bacterial meningitis have higher rates of incidence in the 
summer months.  Although this study excludes the majority of the study population with which 
we are concerned, it suggests that for more mature infant populations, the initial measurements 
of CSF can be predictive of bacterial and viral meningitis.  More importantly, it also suggests 
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that no single criterion can accurately predict meningitis and that multiple factors need to be 
taken into consideration.  More studies are needed on infant populations <1 month of age to 
ensure that these trends are similar across ages.   
In 1992, Bonadio et al. sought to determine the reference values for CSF composition in 
infants 0-4 weeks and 4-8 weeks.  Bonadio et al. justifies his use of 0-4 weeks and 4-8 weeks as 
his age strata because of the use of intramuscular ceftriaxone in the treatment of infants with 
meningitis ages 4-8 weeks.  This drug is an antibiotic that can be used to target both gram 
positive and gram negative bacteria and is a drug of choice in treating infants with suspected 
meningitis.13   In this study, they analyzed data from seventy five full-term infants who presented 
to the Children’s Hospital of Wisconsin with a fever (>38.0°C).  Infants were excluded from the 
study if they had received antibiotics prior to admission, had CSF samples that were indicative of 
traumatic lumbar puncture  (>1000 RBC/mm3), and had CSF gram stains and cultures that were 
positive for bacteria and viruses. Additionally, no infants were included in this study if they had 
seizures prior to being admitted to the hospital13.   Bonadio et al. calculated the means, standard 
deviations, 95% confidence intervals, medians, and 90th percentiles for CSF WBC counts.  For 
protein and glucose levels, they calculated means and standard deviations.   The results from this 
study can be seen in Table 12. 
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Table 12: Bonadio et al.’s Evaluation of Infants Ages 0-4 and 4-8 Weeks of Age for CSF WBC, Glucose, and 
Protein levels13. 
CSF Parameter 0-4 weeks 
n = 35 
4-8 weeks 
n = 40 
P values 
Total WBC count 
(cell/mm3) 
Mean  
(+/- standard 
deviation) 
 
95% confidence 
interval 
 
Median 
 
90th percentile 
 
 
11.00  
(+/- 10.43) 
 
 
7.35-14.57 
 
 
8.50 
 
22.00 
 
 
7.10 
( +/- 9.23) 
 
 
4.27-9.99 
 
 
4.50 
 
15.00 
 
 
.0016* 
Glucose (mg/100mL) 
(+/- standard 
deviation) 
 
46.0  
(+/- 10.3) 
46.0  
(+/- 10.1) 
Not Significant 
Protein (mg/100mL) 
(+/- standard 
deviation) 
 
84.0  
(+/- 45.1) 
59.0 
(+/- 25.3) 
.0007** 
* test performed using the Wilcoxin Rank Sum Test 
**test performed using the student’s t-test 
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As these data show, significant differences exist between infants aged 0-4 weeks and 4-8 
weeks in terms of WBC and protein levels.  Values were not significant for glucose levels, 
however.  These data suggest that, for infants 0-4 weeks of age, 90% will have CSF WBC counts 
less than 22 cells/mm3 and for infants 4-8 weeks, 90% will have values less than 15 cells/mm3.13  
These values are vastly different from those seen in previous studies and can be attributed to 
better inclusion criteria.   Overall, we believe the study design used by Bonadio et al. is sound, 
and, in fact, the majority of the criteria used to identify study populations will be used in our 
study as well.  One improvement that we argue is necessary is to further stratify the infants by 
week of age.  We believe that, if differences exist between infants aged 0-4 weeks and 4-8 
weeks, there may also be significant differences in infants by week of age. 
The next study on normal CSF values in infants was done in 1996 by Ahmed et al.  This 
study used the recently advanced enterovirus PCR tests to help make inclusion criteria more 
stringent and precise.  This study used two prospective studies from June, 1993 to October, 1994 
in Children’s Medical Center of Dallas.  The inclusion criteria included full term infants who had 
“an atraumatic lumbar puncture (<1000 RBC/mm3), no prior antibiotic therapy, sterile blood, 
CSF, and urine bacterial cultures, negative CSF viral culture, and negative CSF PCR for 
enteroviruses”14.  CSF total WBC counts were determined using the Neubauer counting chamber 
and protein and glucose concentrations were determined using standard methods.  Together, 207 
infants younger than 30 days were selected, and of these 108 met all inclusion criteria.   The 
results can be seen for week of age in Table 13. 
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Table 13: Ahmed et al.’s Study of Infants Ages 0-30 Days for CSF WBC, Protein, and Glucose levels14. 
CSF Parameter 1 week  
0-7 days 
N=17 
2 weeks 
8-14 Days 
N=33 
3 weeks 
15-21 days 
N=25 
4 weeks  
22-30 days 
N=33 
WBC 
(cells/mm3) 
Mean  
(+/- standard 
deviation) 
 
95% confidence 
interval 
 
Median 
 
Range  
 
90th percentile 
 
 
15.30  
(+/- 30.30) 
 
 
12.00 - 18.10 
 
 
6.00 
 
0-13.00 
 
18.00 
 
 
5.40  
(+/- 4.40) 
 
 
4.60 - 6.10 
 
 
6.00 
 
0-18.00 
 
10.00 
 
 
7.70  
(+/-12.10) 
 
 
6.30 - 9.10 
 
 
4.00 
 
0-62.00 
 
12.50 
 
 
4.80  
(+/-3.40) 
 
 
4.10 - 5.40 
 
 
4.00 
 
0-18.00 
 
8.00 
Protein (mg/dL) 
(+/- standard 
deviation) 
80.8  
(+/- 30.8) 
69.0  
(+/-22.6) 
59.8  
(+/- 23.4) 
54.1  
(+/-16.2) 
Glucose 
(mg/dL) 
(+/- standard 
deviation) 
45.9  
(+/- 7.5) 
54.3 
(+/- 17.0) 
46.8 
(+/- 8.8) 
54.1  
(+/- 16.2) 
 
This study showed that significant differences existed between infants for WBC counts 
based on week of age.  Protein levels were significantly higher in the first two weeks of life than 
in the 3rd and 4th weeks14.  Despite these findings, we feel that this study was limited by sample 
size.  Their 1st week cohort only had 16 patients, whereas the others had nearly double this.  This 
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is not balanced in terms of numbers in the other categories and although the difference is not 
large enough to affect the power of the study and the ability for statistical differences to be 
determined, we feel a larger sample size should be used.  By using similar inclusion criteria and 
a larger sample size, we will be better able to determine whether real differences exist in infants 
by week of age for CSF WBC, glucose, and protein levels.  Additionally, we feel as though 
combining Bonadio et al.’s findings with this study would be beneficial.  That is, stratifying 
infants less than two months old by their age in weeks and determining the values will be the 
most best way to generate appropriate values for normal CSF WBC, protein, and glucose. 
These studies, taken over nearly a 70 year period, have shown that the question of 
addressing normal CSF values for infants is a difficult one.  Besides age, other factors, including 
disease status, lumbar puncture success, antibiotic treatment, and gestational outcome (full term 
or preterm), need to be included when choosing patients to study.  We believe that these studies 
have provided excellent background for our current study and have shown us what is important 
to include when choosing our own study population.  We feel as that we can improve on these 
studies by adopting stringent inclusion criteria and by having a large sample size for all age 
groups.    
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2.0  MATERIALS AND METHODS 
2.1 CHART SELECTION AND REVIEW 
For this study, three separate cohorts were used from three different time periods ranging from 
1995 to 2008. The study designs were approved individually by the University of Pittsburgh 
Institutional Review Board (IRB).  Dates, reference names, number of observations, and analysis 
variables that were collected can be seen in Table 14. 
 
Table 14: Summary Characteristics of the Cohorts Used for this Analysis. 
Date Collected Date Observed Reference Name Number of 
Observations 
Analysis 
Variables 
1999 March 1995 – 
February 1996 
1995 cohort 536 CSF WBC 
CSF RBC 
2003 December 2001-
December 2002 
2002 cohort 446 CSF WBC 
CSF RBC 
CSF Glucose 
CSF Protein 
2009 January 2008 – 
February 2009 
2008 cohort 415 CSF WBC 
CSF RBC 
CSF Glucose 
CSF Protein 
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The inclusion of three cohorts of infants is to determine if there are differences in the 
CSF constituent characteristics throughout time and to examine if significant changes in these 
values exist depending on birth cohort.  Cases were identified using a retrospective chart review.  
For the first two cohorts, a paper chart review was performed using an honest broker system to 
de-identify patient information for analysis.  For the third cohort, records were selected using an 
electronic database that automatically excludes identifying information and includes only factors 
necessary for analysis.  Potential cases were identified as infants who presented to Children’s 
Hospital of Pittsburgh’s emergency room with a fever and other generalized symptoms of 
possible meningitis.  Infants who had a lumbar puncture performed in the emergency room or 24 
hours after admittance to the hospital were eligible to be screened for inclusion in this study.  
Infants were excluded from the study if they had a positive CSF bacterial culture, a positive CSF 
viral culture, a positive CSF viral PCR, the presence of a ventriculoperitoneal shunt, recent 
neurosurgery, had been on antibiotics prior to or at the time of the lumbar puncture, were born 
prematurely (< 36 weeks gestation), or had had seizures prior to presentation in the emergency 
room.  Infants were included if they had a CSF RBC count < 1000 cells/mm3, a CSF WBC count 
<100 cells/mm3, and were younger than 60 days (or 8 weeks) of age.  Additionally, for the 
second and third cohort, cases were included only if they had complete documentation of the 
CSF glucose and CSF protein along with the CSF WBC count.   
The 1995 cohort study design was approved by the University of Pittsburgh IRB, study 
number CHP 02-120.  A physical chart review identified 536 infants between March of 1995 and 
February of 1996 who had undergone a lumbar puncture upon presentation to the Emergency 
room of Children’s Hospital of Pittsburgh.  Unlike the other two cohorts, only CSF WBC and 
CSF RBC data were collected.  CSF glucose and CSF protein were not included in this 
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collection.  From the charts a de-identified database was constructed which included the date of 
the lumbar puncture, birth date, CSF WBC counts, CSF RBC counts, and CSF culture results.   
The sex of the patient was not recorded in this chart review.  Because we do not suspect that 
gender affects CSF WBC, glucose, or protein levels in infancy, we were not concerned with this 
lack of information. All 536 infants included in this study met the criteria outlined above. 
The 2002 cohort study design was approved by the University of Pittsburgh IRB, study 
number 04051761.   A physical chart review identified 446 infants who presented between 
December 2001 and December 2002 eligible for screening.  From these files, a de-identified 
database was created that included the information described in Table 15. 
 
Table 15: Data Collected from 446 Patient Charts from April 2003 to April 2005. 
Data Collected from Patient Records in Cohort 2 
Birth date Date of Lumbar Puncture 
Age in Days Sex 
Gestational Age Reason for Lumbar puncture 
Temperature in the ER Previous antibiotic Therapy 
CSF WBC CSF RBC 
CSF glucose CSF protein 
Peripheral WBC Peripheral Glucose 
Gram Stain Result – Bacteria Bacterial Culture Result of CSF 
Blood Culture Result Urine Culture Result 
Viral CSF culture result Viral PCR results 
Final Diagnosis on ER Chart Final Diagnosis on Hospital Chart 
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These 446 infants were included for statistical analysis if they met the criteria outlined 
previously.  Following application of these criteria, 271 infants remained for statistical analysis.  
A detailed schematic of infants included for statistical analysis can be seen in Figure 10. 
 
 
 
*These infants were those who met inclusion and exclusion criteria for further study. 
 
 
 
 
The 2008 cohort was collected in March 2009 using Cerner electronic medical records of 
patients who were less than 60 days of age who presented at Children’s Hospital between 
January 2008 and February 2009 and met the inclusion and exclusion criteria.  This study was 
Figure 10: A Flow Chart of Infants Selected from December 2001 to December 2002. 
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approved by the University of Pittsburgh IRB, study number PRO08090308.  Data collected for 
this cohort included age in days at the time of lumbar puncture, time from entry into ER or 
hospital to lumbar puncture, CSF WBC, CSF RBC, CSF protein, CSF glucose, and CSF culture 
results.  Again, sex was not included in this chart review.  Charts were checked for positive CSF 
bacterial or viral cultures or PCRs.   Following collection, charts were checked by hand to see 
whether CSF pleocytosis existed (CSF WBC > 10cells/mm3) to ensure that all infants were being 
included only in the study if they met the criteria described previously.  The third cohort had 415 
observations.  A flow chart can be seen in Figure 11 to show the progression of criteria used to 
identify 258 cases for statistical analysis. 
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*These infants were those who met inclusion and exclusion criteria for further study. 
 
 
Finally, the datasets were combined to determine if the variance between populations was 
low enough so that the observations could be combined and one set of data values could be made 
to describe the normal values of CSF WBC, CSF glucose, and CSF protein for infants.  When 
combined, the datasets were screened using the same inclusion and exclusion criteria as the 
individual cohorts, except observations were not discarded if CSF protein or CSF glucose were 
absent, as the entire 1995 dataset lacks these measurements.  That means that there are 26 
additional observations in the combined dataset that were not included for analysis in the 
Figure 11: A Flow Chart of Infants Selected from January 2008 to February 2009. 
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individual analysis.  Combining the datasets led to 1,397 infants.  Following the application of 
inclusion and exclusion criteria, 1,019 infants were available for statistical examination.  A flow 
chart of the cases included can be seen in Figure 12. 
 
*These infants were those who met inclusion and exclusion criteria for further study. 
 
Figure 12: A flow chart of infants combined from the 1995, 2002, and 2008 cohort. 
 43 
2.2 STATISTICAL ANALYSIS 
All data were analyzed using SAS Version 9 or Stata10.1.  To determine if it was appropriate to 
pool the observations from the three cohorts, the variance between the cohorts needed to be 
analyzed to determine if it was the same for all cohorts.  To start, data were stratified by age and 
gender (for the 2002 cohort) to make sure that no significant differences existed between the 
strata. The data were assessed for normality in respect to the major variables of interest (CSF 
WBC, glucose, and protein levels) using histograms and Kolmogorov-Smirnov tests for 
normality.  If the data were normally distributed, differences between cohorts by age in weeks 
were assessed using Analysis of Variance (ANOVA).  If the data were found not to be normally 
distributed, log-transformations were attempted to normalize the values. If the data were not 
normally distributed following transformation, a Kruskal-Wallis test was run on the data to 
determine whether significant differences existed between the variables of interest (CSF WBC, 
CSF glucose, and CSF protein) and age in weeks26.  To compensate for the number of tests being 
done repeatedly, a Bonferroni adjustment was applied to these p values to determine significant 
differences26.  In our analysis, we assumed an alpha of .05 and divided by 9 (one for each of our 
week stratifications) to give a Bonferroni adjusted critical p-value of .0056.  If we found no 
significant differences, we assumed that it was possible to pool the observations and generate 
one set of means and confidence intervals for CSF WBC, protein, and glucose.  These values 
were generated using the methods described above for the individual cohorts.  If significant 
differences were found, then each cohort was analyzed independently. 
If the observations were pooled, then the three questions being addressed by our study 
were considered for the entire cohort, and not for the individual cohorts. If the cohorts were not 
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pooled for any of the variables being assessed, then the same procedures were carried out as for 
the pooled variables, except each cohort was considered individually. 
  To determine whether there was a change in CSF WBC, glucose, and protein levels by 
age in weeks, locally weighted scatterplot smoothing (LOWESS) plots were constructed for each 
variable to visually assess differences across time27.  If the cohort was normally distributed, then 
ANOVA was used to formally assess differences between the variables by age in weeks.  If the 
cohort was not normally distributed, then the Kruskal-Wallis test was used with week as a 
grouping variable to seek differences by age in weeks.   
If significant differences were found for variables by age in weeks, means for each week 
were calculated using standard methods. Ninety-five percent confidence intervals for the mean 
were generated using standard methods if the variables were normally distributed.  If the 
variables were not normally distributed, the 95% confidence intervals were calculated using the 
non-parametric bootstrap method.  The bootstrap method does not require that the data follow a 
normal distribution, and uses a series of samples with replacement from the original sample to 
estimate the confidence intervals surrounding the mean28. Ten-thousand samples were used to 
generate 95% confidence intervals in this analysis.  If significant differences were not found to 
exist for variables by age in weeks, then the variables were re-categorized by age in months and 
reassessed using the methods described earlier.  If no differences existed within these divisions, 
then means and 95% confidence intervals were calculated for the entire cohort as one age group 
using the methods described previously.   
To generate a “normal” range of values that can be expected for CSF WBC, protein, and 
glucose, the median and the 10th and 90th percentiles were calculated using standard methods26. If 
differences were found between age groupings, each age category had its own median and 
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percentiles calculated.  If no differences were found, the median and percentiles were calculated 
for that variable for the entire cohort. 
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3.0  RESULTS 
3.1 DESCRIPTION OF COHORTS 
As previously stated, three cohorts were considered for analysis.  To observe the relative 
frequencies of the observations, the data were stratified by age in weeks.  The number of patients 
in each cohort, the relative frequencies, medians, and ranges for CSF WBC, glucose, and protein 
for each age in weeks can be seen in Table 16.  To determine age in weeks, the age in days (date 
of lumbar puncture – date of birth) was divided by seven.  All infants were less than 60 days of 
age, and any infants greater than 56 days old (8 weeks) were not included in the analysis.  Less 
than seven days was denoted as 0-1 week, 7-14 days as 1 week, 14-21 days as 2 weeks, etc.   
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Table 16: Descriptive Characteristics of the 1995, 2002, and 2008 Cohorts. 
 Age 
(weeks) 
0-1 1 2 3 4 5 6 7 8 
  
1995 N 64 52 46 83 76 74 77 56 8 
Percentage 
11.94 9.70 8.58 15.49 14.18 13.81 14.37 10.45 1.49 
CSF 
WBC* 
Median 
Range 
 
 
 
4.5 
0-33 
 
 
3.00 
0-20 
 
 
3.00 
0-23 
 
 
3.00 
0-33 
 
3.00 
0-44 
 
2.00 
0-14 
 
 
1.00 
0-22 
 
2.00 
0-33 
 
 
1.50 
0-3 
2002 N 37 28 25 37 38 36 33 27 10 
Percentage 13.65 10.33 9.23 13.65 14.02 13.28 12.18 9.96 3. 69 
CSF 
WBC* 
Median 
Range 
 
 
7.00 
0-69 
 
 
2.50 
0-20 
 
 
3.00 
0-50 
 
 
2.00 
0-33 
 
 
2.00 
0-96 
 
 
1.00 
0-93 
 
 
2.00 
0-50 
 
 
2.00 
0-22 
 
 
2.00 
0-10 
CSF 
glucose** 
Median 
Range 
 
 
 
49.00 
32-104 
 
 
51.5 
36-80 
 
 
49.0 
33-64 
 
2.00 
42-77 
 
 
 
49.5 
40-               
137 
 
 
53.0 
39-81 
 
 
52.00 
41-88 
 
5
52.00 
41-88 
 
 
52.5 
41-
70 
 
CSF 
protein** 
Median 
range 
 
 
 
96.0 
55-219 
 
 
76.0 
5-124 
 
 
67.0 
31-
160 
 
 
68.0 
34-99 
 
 
56.0 
35-87 
 
 
60.0 
24-
110 
 
 
47.0 
24-91 
 
 
53.0 
30-
234 
 
 
59.0 
20-
132 
2008 N 17 21 36 21 36 36 44 29 18 
Percentage 6.59 8.14 13.95 8.14 13.95 13.95 17.05 11.24 6.98 
CSF 
WBC* 
Median 
Range 
 
 
 
 
4.00 
0-9 
 
 
3.00 
0-10 
 
 
2.00 
0-15 
 
 
2.5 
0-12 
 
 
2.0 
0-15 
 
 
2.0 
0-10 
 
 
2.0 
0-9 
 
 
2.0 
0-24 
 
 
2.0 
0-7 
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Table 16: Continued 
CSF 
glucose** 
Median 
Range 
 
 
 
45.0 
34-65 
 
 
47.0 
29-
113 
 
 
44.0 
32-81 
 
 
43.0 
33-78 
 
 
46.5 
22-76 
 
 
44.5 
34-87 
 
 
47.0 
0-125 
 
 
46.0 
37-71 
 
 
45.5 
36-
105 
 
 
 
 
CSF 
protein** 
Median 
range 
 
 
 
105.0 
44-185 
 
 
74.0 
52-
120 
 
 
63.5 
37-
118 
 
 
71.0 
41-
275 
 
 
66.5 
30-
126 
 
 
51.00 
31-
140 
 
 
49.5 
24-
127 
 
 
59.00 
29.0-
134 
 
 
47.0 
26-
84 
  *CSF WBC values are in cells/mm3 
  **CSF glucose and CSF protein are in mg/100mL 
 
The 1995 cohort contained 536 infants and was relatively evenly distributed in terms of 
weeks, except for the 8 week age category.  This discrepancy in observations for the 8 week old 
category will affect the power for comparisons involving this group, and thus the associations 
may not be as strong as for the other week categories.    
Once the 2002 cohort was modified to include our inclusion criteria, there were 271 
observations left in our data set (Figure 9).  Before analysis could begin, we wanted to observe 
the relative frequencies of our data in terms of gender and age.  The 2002 data set had 160 males 
and 111 females, or 59.04% and 40.96% respectively.  Although there are more males than 
females in this dataset, no data have been found in the literature that suggest that CSF WBC, 
glucose, and protein levels differ among newborn males and females.  Next, the dataset was 
stratified by age in weeks to determine whether any major differences existed between the strata. 
As seen in the 1995 cohort, the 2002 cohort has fairly similar frequencies of patients across the 
week categories, except for the week 8 range. The other week categories have between 25 and 40 
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infants in each group.  The 8 week range has only 10 infants.  As previously discussed, this can 
affect the power of comparisons involving this stratum. 
The 2008 dataset had 258 observations and included data for CSF WBC, CSF glucose, 
and CSF protein.  To start, the data were stratified by week to determine the relative distribution 
by age in weeks for the infants.  Unlike the 1995 and the 2002 cohorts, the 2008 dataset had a 
relatively limited number of observations in the first and eighth weeks. The majority of the 
values were seen in weeks 2-6.  The stratum sizes ranged from 17 to 44 per week. 
3.2 COMBINING THE COHORTS 
Before analysis was done to see whether the values varied significantly for CSF WBC, glucose, 
and protein between the age stratifications, the normality of the CSF WBC variables was 
assessed.  Normality is a key factor when choosing which statistical analyses to perform to 
ascertain significance.   A histogram of the each variable’s distribution was made for each cohort 
with a normal curve superimposed to help visually assess normality.  Additionally, a formal 
normality test, the Kolmogorov-Smirnov test, was run. The Kolmogorov-Smirnov test was 
chosen for this analysis because it is appropriate for larger sample sizes26. All of the variables 
were found not to be normally distributed as determined by this formal test (p value <0.05).  The 
histograms for each variable can be seen in Figures 13-15. 
 
 
 50 
0 4 8 12 16 20 24 28 32 36 40 44
0
5
10
15
20
25
30
35
40
45
P
e
r
c
e
n
t
csfwbc  
5 15 25 35 45 55 65 75 85 95
0
20
40
60
80
100
P
e
r
c
e
n
t
CSFWBC  
0 3 6 9 12 15 18 21 24
0
10
20
30
40
50
P
e
r
c
e
n
t
CSFWBC  
Figure 13: Distributions of CSF WBC for the 1995, 2002, and 2008 Cohorts. 
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Figure 14: Distribution of CSF Glucose for the 2002 and 2008 Cohorts. 
 
 
 
 
 
 
 
 52 
 
30 50 70 90 110 130 150 170 190 210 230
0
5
10
15
20
25
30
35
P
e
r
c
e
n
t
CSFPRO  
 
Figure 15: Distribution of CSF Protein for the 2002 and 2008 Cohorts. 
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To transform the variables in an attempt them follow a normal distribution, the log of 
each variable was calculated.  Because Log(0) is an undefined number, the transformations were  
calculated using the following equations: 
LogWBC = Log10 (CSF WBC + 1) 
LogGlu = Log10 (CSF Glucose + 1) 
LogPro = Log10 (CSF Protein + 1) 
Once the transformations were completed, normality was reassessed using the same 
procedures as used on the untransformed variable.  Following transformation, none of the 
variables passed the test for normality except for CSF protein in the 2002 cohort (Kolmogorov-
Smirnov p-value >0.150).  Other transformations were attempted in addition to the Log10 
transformation, but none were successful in making the variable normally distributed.  Because 
no transformation could make all the variables normally distributed, it was decided that non-
parametric measures would be used to analyze the dataset. 
When the datasets were combined and the inclusion criteria were applied to the 
observations, there were 1,091 infants available for statistical analysis.  Because the 1995, 2002, 
and 2008 datasets had data for CSF WBC, all 1,091 infants were included for analysis for this 
variable.  But because the 1995 dataset did not include data for CSF glucose or CSF protein, only 
the cases from the 2002 and 2008 dataset were included for this analysis.  This left 530 infants 
available for analysis for the CSF glucose and the CSF protein variables (after removing all 
observations which did not have CSF glucose and protein observations in the 2002 and 2008 
cohorts).  The age distributions of the infants were calculated and the results of this distribution 
can be seen in Table 17.  Each week category has a similar number of observations, except for 
the week 8 category, which had significantly fewer observations.  This trend was seen for the 
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1995, 2002, and 2008 individual datasets as well, so it is no surprise that it persists when the sets 
are combined.  This low number of observations can have effects on the power of the results for 
analysis on the 8-week old infants. 
 
Table 17: Age Distribution of the Combined Cohorts. 
Age (weeks) 0-1 1 2 3 4 5 6 7 8 
Number 
CSF-WBC 
analysis 
 
120 
 
104 
 
109 
 
141 
 
156 
 
150 
 
161 
 
114 
 
36 
Percentage 11.0 9.53 9.99 12.92 14.30 13.75 14.76 10.45 3.30 
Number 
CSF 
Glucose and 
Protein 
Analysis 
 
 
54 
 
 
49 
 
 
61 
 
 
58 
 
 
74 
 
 
72 
 
 
77 
 
 
56 
 
 
29 
Percentage 10.21 9.26 11.53 10.96 13.99 13.61 14.56 10.59 5.29 
 
In order to determine whether the data from the three cohorts could be combined for 
analysis to generate a single set of values, non-parametric ANOVA using the Kruskal-Wallis test 
and a Bonferroni adjustment were used.  We wanted to determine whether there are significant 
differences between the values for CSF WBC between the 1995, 2002, and 2008 datasets and 
between the values for CSF glucose and protein for the 2002 and 2008 datasets.   Because our 
data are not normally distributed, we cannot use a standard regression approach to determine 
this.  The data were analyzed using a Kruskal-Wallis test for each week to see whether the data 
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values could be pooled for the three time periods.  Because there are 9 week categories which we 
are concerned about pooling, we will repeat each of these tests 9 times for CSF WBC, glucose, 
and protein.  This necessitates the use of an adjusted alpha.  To maintain an alpha of 0.05 across 
the collection of tests, we divided our alpha by nine to determine what is statistically significant.  
Our new p-value following this adjustment is 0.0056.  If the p-values for each test are greater 
than this value, we can assume that no differences exist between the three cohort time periods 
and they can be pooled to generate a single range of values for the variable. 
 The results of the Bonferroni-adjusted Kruskal-Wallis test for CSF WBC values can be 
seen in Table 18.   We find that no significant differences exist between the cohorts for each 
week.  This means that we are able to generate a single set of values that accurately characterize 
CSF WBC count in infants by age in weeks. 
 
Table 18: Kruskal Wallis using the Bonferroni Adjustment for CSF WBC Values Across the 1995, 2002, and 
2008 Cohorts. 
Week Chi-Square Statistic P-value 
0-1 3.778 0.153 
1 0.039 0.981 
2 1.425 0.491 
3 0.796 0.672 
4 1.688 0.430 
5 0.244 0.885 
6 0.595 0.743 
7 0.424 0.809 
8 1.261 0.532 
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The results for the Bonferroni adjusted Kruskal-Wallis test for CSF glucose differences 
among all cohorts can be seen in Table 19.   Unlike the CSF WBC, we do find some significant 
differences among the observations for this variable.  Significant differences existed between the 
2002 and 2008 cohorts for weeks 3, 5, and 6.   Because of these differences, we will not pool the 
observations for CSF glucose. 
 
Table 19: Kruskal Wallis using the Bonferroni Adjustment for CSF Glucose Values Across the 2002, and 
2008 Cohorts. 
Week Chi-Square Statistic P-value 
0-1 3.105 0.078 
1 5.536 0.0184 
2 2.447 0.118 
3 14.436 <0.0001* 
4 5.946 0.0148 
5 24.693 <0.0001* 
6 12.8515 0.0003* 
7 7.5595 0.006 
8 2.365 0.124 
* = significant results, p<0.0056 
 
The results of the Kruskal-Wallis Bonferroni adjusted test for CSF protein for the 
combined dataset can be seen in Table 20.  Similarly to the CSF WBC, there exist no statistically 
significant differences between CSF protein values among the 2002 and 2008 cohorts.  This 
indicates that these observations can be pooled to generate a single set of values for CSF protein. 
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Table 20: Kruskal Wallis using the Bonferroni Ajustment for CSF Protein Values Across the 2002, and 2008 
Cohorts. 
Week Chi-Square Statistic P-value 
0-1 0.083 0.773 
1 0.7342 0.3915 
2 0.560 0.454 
3 0.2435 0.6217 
4 5.2440 0.0220 
5 0.8793 0.3484 
6 1.5441 0.2140 
7 0.0638 0.8805 
8 0.8315 0.3618 
 
These tests tell us that we will be able to pool the values for CSF WBC and CSF protein, 
but not for CSF glucose.   
3.3 DETERMINING WHETHER DIFFERENCES EXIST FOR CSF WBC, CSF 
GLUCOSE, AND CSF PROTEIN BY AGE IN WEEKS 
The first question we wanted to answer with this analysis was whether differences exist among 
the variables as infants’ age increases by weeks.  In order to address this question, LOWESS 
curves were made to visually analyze the trends through time.  The LOWESS function calculates 
the means for a set of values in a window across the horizontal axis.  Depending on the width of 
the window selected, the line can fit all of the data points (sense all the noise in a sample) or can 
generate a linear relationship between the data points.  We used a window of 0.6 to generate a 
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smooth curve that describes the best relationship between our variables.  These plots can be seen 
in Figures 16, 17, and 18. 
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Figure 16:  LOWESS Smooth Curve of CSF WBC for the 1995, 2002, 2008, and Combined Cohorts. 
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Figure 17: LOWESS Smooth Curve of CSF Protein for the 2002, 2008, and Combined Cohorts. 
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Figure 18: LOWESS Smooth Curve of CSF Glucose for the 2002 and 2008 Cohorts. 
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From these plots, we can see that for CSF WBC and protein, a decreasing trend does 
seem to be present that corresponds with increasing age.  The values for CSF WBC and protein 
appear to be highest at birth and then decrease in a relatively consistent manner as age in weeks 
increases.  For CSF glucose, however, we do not see this trend.  In both the 2002 and 2008 
cohorts, it appears as though the CSF glucose counts are relatively constant as age increases.   
In order to formally address these obesrvations, non-parametric Kruskal-Wallis ANOVA 
tests were used on the pooled observations for CSF WBC and protein and on the individual 
cohorts for CSF glucose to test for differences between age groups.  For CSF WBC, we found a 
chi-square test statistic of 92.077 with a p-value <0.0001.  This indicates that significant 
differences exist for CSF WBC within the cohort among our age categories and confirms that the 
temporal trend seen visually in the LOWESS plot is significant.   For CSF protein, the Kruskal-
Wallis test produced a Chi-Square statistic of 118.8440 and a p-value <0.0001.  This indicates 
that significant differences exist among the age in weeks for CSF protein and confirms the trend 
seen in the LOWESS plot.  These findings indicate that it is appropriate to generate unique 
means, 95% confidence intervals, and expected ranges for CSF WBC and CSF protein for each 
week category. 
 For CSF glucose, the examination of the 2002 cohort produced a Chi-Square statistic and 
p-values of 10.79 and 0.2138, respectively.  For the 2008 cohort, the Kruskal-Wallis test 
produced a Chi-Square statistic of 7.541 and a p-value of 0.4795.  These values indicate that no 
significant differences exist between glucose for the age stratifications in either cohort.  In an 
attempt to see whether significant differences existed among broader age categories, the same 
tests were repeated on the data stratified by age in months.  The results of these tests were also 
found to be not significant.  This indicates that for CSF glucose no significant differences exist 
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between birth and 8 weeks of age, and so a single set of values should be calculated for each 
cohort. 
3.4 GENERATING MEANS AND CONFIDENCE INTERVALS FOR CSF WBC, CSF 
GLUCOSE, AND CSF PROTEIN 
One of the main goals of this research study was to generate a single set of clinically relevant 
means and confidence intervals that would guide physicians in knowing what normal values are 
for infants less than two months of age.  Because CSF WBC, glucose, and protein were not 
normally distributed, methods based on normality could not be used to generate 95% confidence 
intervals.  In order to obtain these values, bootstrap analysis was used.  Bootstrap analysis is a 
non-parametric method that does not depend on a normal distribution to generate confidence 
intervals of the means (for more discussion, see materials and methods). The means were 
calculated using standard descriptive analysis.  The means from standard descriptive analysis and 
95% confidence intervals from the bootstrap analysis for CSF WBC and protein can be seen in 
Tables 21 and 22, respectively. 
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Table 21: Means and 95% Confidence Intervals for CSF WBC for all Cohorts Combined. 
Age  
(weeks) 
Mean WBC 
(cells/mm3) 
Lower Confidence 
Interval 
Upper Confidence 
Interval 
0-1 8.63 6.73 10.83 
1 3.87 3.52 5.37 
2 4.89 3.70 6.09 
3 4.54 3.31 5.22 
4 4.33 2.35 4.38 
5 3.02 2.22 5.59 
6 3.17 2.29 4.12 
7 3.15 2.16 3.93 
8 2.22 1.83 4.78 
 
 
Table 22: Means and 95% Confidence Intervals for CSF Protein for all Cohorts Combined. 
Age in Weeks Mean Protein 
(mg/100mL) 
Lower Confidence 
Interval 
Upper Confidence 
Interval 
0-1 106.44 94.12 115.22 
1 77.61 75.45 88.19 
2 71.03 64.74 77.85 
3 68.68 63.31 79.42 
4 62.15 57.77 66.70 
5 60.15 55.33 65.11 
6 53.35 49.25 57.73 
7 63.63 55.46 73.38 
8 54.18 44.97 60.97 
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The same methods were used to generate values for CSF glucose, although only mean 
and set of confidence intervals was generated for each cohort.  The means and 95% confidence 
intervals for the 2002 and 2008 cohorts for CSF glucose can be seen in Table 23. 
 
Table 23: Means and 95% Confidence Intervals for CSF Glucose for the 2002 and 2008 Cohorts. 
Cohort Mean Glucose 
(mg/100mL) 
Lower Confidence 
Interval 
Upper Confidence 
Interval 
2002 52.97 51.72 54.37 
2008 46.99 45.71 48.33 
 
 
3.5 GENERATING NORMAL RANGES FOR CSF WBC, CSF GLUCUSE, AND CSF 
PROTEIN 
The final question that we wanted to address in this study was “What values could physicians 
expect to see for normal infants?”.  That is, “How high is too high?” in infants less than two 
months of age.  In order to answer this question, we set out to create a set of values for each 
variable that could be used by physicians to help better diagnose and initiate treatment in infants 
presenting with fever in emergency rooms.  For CSF WBC and protein, these ranges were 
compiled among the combined cohort for each week stratification.  For CSF glucose, ranges 
were calculated for the 2002 and 2008 cohorts.  Because physicians are mainly concerned with 
the high-end ranges for CSF WBC, only the upper-percentiles will be reported for this variable.  
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CSF glucose and protein will include both upper and lower percentiles, as values can be elevated 
or depressed, depending on the condition.  The values for these variables can be seen in Tables 
24, 25, and 26 for CSF WBC (cells/mm3), protein (mg/100mL), and glucose (mg/100mL), 
respectively. 
 
Table 24: Medians, 75th, and 90th Percentiles for CSF WBC for all the Cohorts Combined. 
Age  
(weeks) 
CSF WBC 
(cells/mm3) 
Median 
75th percentile 90th percentile 
0-1  6.0 9.0 26.0 
1  3.0 6.0 9.0 
2  3.0 7.0 9.0 
3  2.0 4.0 9.0 
4  2.0 4.0 8.0 
5  2.0 3.0 6.0 
6  2.0 3.5 8.0 
7  2.0 3.0 7.0 
8  2.0 3.0 7.0 
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Table 25: 10th, 25th, Median, 75th, and 90th Percentiles for CSF Protein for all Cohorts Combined. 
 CSF Protein (mg/100mL) 
Age 
(weeks) 
10th percentile 25th percentile Median 
 
75th percentile 90th percentile 
0-1 62.0 78.0 98.0 132.0 153.0 
1 53.0 64.0 76.0 86.0 103.0 
2  44.0 56.0 66.0 84.0 106.0 
3  43.0 53.0 68.0 78.0 85.0 
4  38.0 49.0 59.0 74.0 84.0 
5  37.0 43.0 56.0 75.0 85.0 
6  32.0 41.0 48.0 64.5 84.0 
7  34.0 43.0 50.0 76.0 105.0 
8  29.0 38.5 50.5 62.0 84.0 
 
 
Table 26: 10th, 25th, Median, 75th, and 90th Percentiles for CSF Glucose for the 2002 and 2008 Cohorts. 
 CSF Glucose (mg/100mL) 
Cohort 10th percentile 25th percentile Median 
 
75th percentile 90th percentile 
2002 43.0 47.0 51.0 56.0 62.0 
2008 38.0 42.0 46.0 50.0 60.0 
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4.0  DISCUSSION 
The generation of a set of standard values for CSF parameters in infants has long been an area of 
focus among health care professionals.  This set of values can be useful in aiding in the early 
diagnosing and management of febrile infants who may have bacterial or viral meningitis. 
Although the risk of meningitis in the United States has dropped in recent years due to the 
widespread use of vaccines for some of the causative agents, including H. influenzae and Group 
B Streptococcus, the risk of meningitis to infants is substantial. This study utilized three 
independent chart reviews to produce sets of values for each of these cohorts as well as analyze 
if it was appropriate to pool the observations over time. 
Using a sample size far larger than previous studies, this study proved that lab methods 
have remained constant through time for interpreting CSF WBC and CSF protein levels.  This 
study also generated means, 95% confidence intervals, and expected percentiles for these 
surrogate markers of infection. CSF glucose values were found to vary between cohorts, but 
were not found to vary within cohorts.  Because of this, values were generated for CSF glucose 
for the 2002 and 2008 cohorts separately.  Because these values did not follow a normal 
distribution and generally could not be transformed to generate a set of values that did, non-
parametric methods were employed to generate these confidence intervals and assess for 
differences among age in weeks for the surrogate markers of infection.   CSF WBC, glucose, and 
protein are relatively easy measures for physicians to obtain and analyze in infants who present 
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with fevers in emergency rooms.  It has long been known that these values vary over time in 
infants, although it was not certain to what degree and in what time frames differences should be 
assessed. 
Elevated WBC counts in the CSF are typical indicators of infection, whether it be of 
bacterial or viral origin.  In addition, CSF WBC counts appear to be elevated directly following 
birth.  One of the major problems in the field of emergency pediatrics has been the uncertainty 
surrounding the questions, “How high is too high?” or “What is the normal expected value?” for 
these parameters in CSF.  In our study, we found that CSF WBC counts are the highest directly 
following birth.  This phenomenon has been explained in a number of ways, including the 
possibility that the blood-brain barrier is far more permeable directly following birth than later in 
life10-14.  Another hypothesis to explain the elevated WBC count is that the actual process of 
being born may be “traumatic” to the infant.  The stress of being born can lead to inflammation 
of the infants’ meninges and the innate immune system releasing more cells to the CSF, even 
though no infection is present to warrant their presence. As the infant ages, the WBC values 
decrease as the blood brain barrier matures and becomes less permeable, and as the infant 
recovers from the birthing process.  Previous studies, such as those conducted by Samson, 
Naidoo, Sarff, Pappu, Portnoy and Olson, Spanos, and Bonadio neglected to consider infants 
stratified by weeks of age4,5,11,13,24,25.  Their methods of analysis included only examining infants 
one day old, less than one week, by month, or by three months.   
This study shows that significant differences exist for infants in the first 8 weeks of life, 
and that important differences exist between infants who are 1 week old as compared to those 
who are 4 and those who are 8 weeks of age.  We found significant differences between age in 
weeks for combined cohorts in terms of CSF WBC and protein.  These tests formally examined 
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the means of the variables. This indicates that infants less than two months of age should not be 
compared to each other using a standard set of values for CSF WBC and protein.   The means 
and 95% confidence intervals calculated for CSF WBC values in the combined cohort can be 
seen in Table 21.   
From this table, we are able to see the value in stratifying infants by age in weeks as 
compared to making broader classifications of infants in terms or age.  From birth to 2 weeks of 
age, we see a difference between the means of nearly 4 cells/mm3 in the CSF WBC, with 
potential differences of 5 cells/mm3 existing when comparing confidence intervals.  From birth 
to 8 weeks of age, we see a difference between the means of over 6 cells/mm3.  These differences 
are clinically significant and it is therefore important to not classify these infants into broad age 
groups.  
Additionally, it may be important for physicians to understand what the typical range of 
values will be for infants.  For CSF WBC, the lowest that is possible is 0 cells/mm3, which may 
not be unexpected.  The upper ranges, however, can be quite high and also vary considerably 
between the week stratifications.  Because physicians are majorly concerned with elevated CSF 
WBC values, the medians, 75th, and 90th percentile values for CSF WBC were calculated.  The 
results of these calculations can be seen again in Table 24. 
Like the means and confidence intervals calculated for CSF WBC, we see that the 
median, 75th, and 90th percentiles drop as age increases.  The rates of decrease are not as obvious 
for the medians and 75th percentiles, but a large drop is seen in the 90th percentile between 
infants 0-1 weeks of age and infants 1 week of age.  This again reinforces the importance of 
looking at infants stratified by weeks in age when attempting to diagnose or decide on early 
treatment options. 
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CSF protein values were also combined across cohorts and used for the generation of a 
standard set of values.  The mechanisms for CSF protein transfer are similar to those for WBC in 
infancy.  Although it is unknown why CSF protein levels are higher directly following birth, it 
has been postulated that the difference can be partially attributed to the immaturity of the blood 
brain barrier10-14.  This temporal trend in protein levels was seen by Widell in 1958.  His study 
found that protein levels were dramatically higher in the first two months of life.  He did not 
stratify infants by week of age and generate means and confidence intervals, however.  
Extending upon his work, we found that the trend seen in CSF WBC largely parallels that for 
CSF protein.  Large differences exist when comparing infants who vary in age by only a few 
weeks.  The means and 95% confidence intervals generated for the infants in this study can be 
seen in Table 22. 
The differences between protein levels in infants of varying age are even more 
pronounced than the trends that were seen for CSF WBC.  When comparing infants ages 0-1 
week and 1 week of age, there is a mean difference in protein of 25 mg/100mL with the potential 
difference being as large as 40 mg/100mL.  This trend increases as age increases, with the mean 
difference between infants 0-1 weeks of age and 8 weeks of age being approximately 50 
mg/100mL and the largest potential difference being 55mg/100mL.  These differences are 
clinically significant and would potentially be missed if infants were grouped according to 
broader age criteria. 
Knowing a reference range of normal values for CSF protein is also important for 
physicians.  Unlike CSF WBC, there could be situations where CSF protein levels could drop.  It 
was decided for this reason to not only include upper tail values for CSF protein, but also include 
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lower tail values.  The 10th, 25th, median, 75th, and 90th percentiles for CSF protein for the 
combined cohort can be seen in Table 25. 
As seen by the expected range of values, large differences also exist between newborn 
infants and those a few weeks old.  Specifically, a large decrease is seen between all percentiles 
between infants ages 0-1 week and 1 week of age.  This trend is seen throughout the cohort as 
age in weeks increases, although the differences begin to level out as the 8 weeks is reached.  
Similarly for CSF WBC, this again reinforces the idea that infants under 2 months of age should 
not be evaluated using the same set of diagnostic values for all age groups. 
The values for CSF glucose did not follow the same temporal trends as CSF WBC and 
CSF protein.  When analyses were being run to determine whether it was appropriate to pool the 
observations across cohort, there were some differences among CSF glucose values depending 
on the age in weeks between 2002 and 2008.  For ages 3 weeks, 5 weeks, and 6 weeks, 
significant differences existed between the values obtained for the 2002 and 2008 cohorts.  
Nearly significant differences also existed for other weeks, although due to the Bonferroni 
adjustment they did not make the cutoff.  In order to determine a clinically relevant reason for 
why this difference existed, the University of Pittsburgh Medical Center’s Laboratory was 
consulted to see if they had changed their standards of analysis.  They reported that although 
they had not changed their methods, they too had noticed a changing trend among CSF glucose 
values over time.  They indicated that they had noticed that over years the CSF glucose values 
had been decreasing.  This trend was also seen in our data analysis.  CSF glucose values for the 
2002 cohort were higher than those for the 2008 cohort.  It follows that some outside source is 
likely causing a variation in population level CSF glucose values that is not related to collection 
or lab analysis.  Because the reason for these differences could not be identified, it was decided 
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to not pool the observations, even though the overall trend was to pool the observations.  
Therefore, CSF glucose was analyzed individually for the 2002 and the 2008 cohorts.   
When non-parametric ANOVA was run on the 2002 and 2008 cohorts for CSF glucose, 
no statistically significant differences existed within cohorts for the values when stratified by age 
in weeks or age in months.  It has been discussed in the literature that CSF glucose levels are 
different in infants as compared to adults, although our data suggest that from birth to two 
months there are relatively few changes in the range of CSF glucose.  For these reasons, CSF 
glucose means and confidence intervals were generated for the entire cohorts, independent of age 
in weeks or months.  The means and 95% confidence intervals for CSF glucose among the 2002 
and 2008 can be seen in Table 23.  
 Looking at these values, we see the trend that was identified by the University of 
Pittsburgh Medical Center’s Laboratory.  Values for the 2008 cohort are lower than those for the 
2002 cohort.  Because the observations were not able to be pooled, we were unable to generate a 
single mean and set of confidence intervals that would be appropriate to use when diagnosing 
infants.   
 Similarly to CSF protein, CSF glucose values could also be expected to be higher or 
lower than normal depending on the cause of infection.  As discussed in the introduction, CSF 
glucose values can vary even depending on the causative agent for meningitis.  In viral 
meningitis, CSF glucose values tend to be increased, but in bacterial meningitis, they are 
decreased.  It was therefore important to generate a wide range of expected values for CSF 
glucose.  The 10th, 25th, median, 75th, and 90th percentiles for CSF glucose can be seen in Table 
26. 
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Looking at these values, it does not seem as though there are large differences between 
the two cohorts in terms of expected ranges, although overall the same trend is upheld:  CSF 
glucose values are higher in the earlier cohort.  Again, because we were not able to pool 
observations between the two cohorts so we were not able to generate a single set of values for 
the range.   
More research will need to be undertaken to understand the changes differences CSF 
glucose values in the different cohorts.  Because lab practices have not changed in the manner in 
which CSF glucose is analyzed, it implies that there is an environmental reason why CSF 
glucose is decreasing in the population.  In Pittsburgh, this trend can be examined by also 
examining serum glucose levels to see if they too have also been decreasing through the years.    
It is possible that changes in infants diet (such as changes to formulas, vitamins, etc) or rates of 
breastfeeding may affect both serum and CSF glucose ratios.   It will be important to investigate 
whether this trend has been seen in other cities besides Pittsburgh.  If this trend has not been 
recognized by other researchers, it is likely that there is something unique about our study 
population which is responsible for the differences.  If data is available, cross sectional studies 
on existing data and new ones could be performed to determine if there is a relationship between 
the factors discussed (breast feeding rates and formula usage) and decreased glucose values. 
Comparing our findings to previous studies that look at similar age strata as ours, we find 
that our estimates vary considerably.  Widell’s study looked at 48 infants and divided infants by 
age in weeks for the first two weeks and then divided them in two week segments following 
this11.  For WBC, he found an average value of 7.5 cells/mm3 for all infants, ranging from birth 
to 60 days11.  He does not specify whether he chose to do this because no significant differences 
existed or for another reason.  Widell did not look at CSF glucose, but he did examine total 
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protein levels.  Total protein levels for Widell’s age strata were significantly lower than ours.  He 
found values of protein ranging from 80.9 to 34.8mg/100mL for infants ages 0-6 days and 42-59 
days, respectively.  Our range of values was 106.44 to 54.18 mg/100mL of protein for infants 0-1 
weeks and 8 weeks, respectively.  These differences could exist because Widell used a different 
method for analyzing protein or because different inclusion criteria were used.  
The next study which has comparable age groupings is Bonadio et al.’s study from 1992.  
Their study examined 35 infants 0-4 weeks of age and 40 infants ages 4-8 weeks of age.  Their 
WBC values were higher than ours, with a mean of 11.0 cells/mm3 for infants ages 0-4 weeks 
and 7.1 cells/mm3 for infants ages 4-8 weeks21.  If we were to average our values together over 
0-4 weeks and 4-8 weeks, we would find approximately 5 cells/mm3 and3 cells/mm3, 
respectively.  Bonadio et al. also examined CSF glucose and CSF protein and it appears that our 
measurements would be comparable if we were using the same age stratification.  Bonadio et al. 
completed this study in 1992, before the widespread use of PCR as a means of identification of 
viral pathogens that cause meningitis.  It is possible that Bonadio et al.’s sample was subject to 
misclassification bias because some of his “normal” cases were actually undiagnosed cases of 
viral meningitis. 
The final study that we can directly compare our findings to is Ahmed et al.’s study from 
1996.    Ahmed et al. found that for infants 0-7 days old, the mean CSF WBC value was 15.3 
cell/mm3 14.  For their other age stratifications, 2 weeks, 3 weeks, and 4 weeks, his findings were 
higher than ours.  This trend did not hold through for all the surrogate markers, however.   The 
protein values we found were consistently higher for each age group.  For glucose, the values 
found by Ahmed et al. matched ours relatively well.  They found means for glucose that ranged 
from 45.9mg/100mL to 54.3mg/100mL14.  Our overall finding was that for infants ages 0-60 
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days the mean value should be 50.09mg/100mL.  It is difficult to say why differences exist in our 
study findings but Ahmed et al.’s study had far fewer infants.  It is possible that different 
inclusion criteria were used that were not as stringent as ours.  It is also possible that different 
techniques were used to measure CSF WBC and CSF protein, although this is not as likely as 
these methods are largely standardized.  
  A comparison of the findings from Widell’s, Bonadio et al.’s, Ahmed et al.’s, and this 
study can be seen in Table 27. 
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Table 27: Summary of Results for Widell, Bonadio, Ahmed, and Chadwick. 
Author Year Population Age Groupings/ 
Strata 
CSF WBC 
(cells/mm3) 
CSF 
Glucose 
(mg/100mL) 
CSF 
Protein 
(mg/100mL) 
Widell11 1958 48 children 
<2 months 
0-6 days 
7-13 days 
14-27 days 
28-41 days 
42-59 days 
7.5 (avg for 
all groups) 
No Data 80.9 
70.4 
53.9 
46.5 
34.8 
Bonadio 
et al.13 
1992 75 infants 
< 8 weeks 
0-4 weeks 
4-8 weeks 
11.0 
7.1 
46.0 
46.0 
84 
59 
Ahmed et 
al.14 
1996 108 infants 
< 30 days 
1 week 
2 week 
3 week 
4 week 
15.3 
5.4 
7.7 
4.8 
45.9 
54.3 
46.8 
54.1 
80.8 
69.0 
59.8 
54.1 
Chadwick, 
Martin, 
Wilson 
2009 1,019 
infants < 
60 days for 
CSF WBC 
 
530 infants 
<60 days 
for CSF 
glucose 
and CSF 
protein  
0-1 Weeks 
 
1 Week 
 
2 Weeks 
 
3 Weeks 
 
4 Weeks 
 
5 Weeks 
 
6 Weeks 
 
7 Weeks 
 
8 Weeks 
8.63 
 
3.87 
 
4.89 
 
4.54 
 
4.33 
 
3.02 
 
3.17 
 
3.15 
 
2.22 
 
 
 
50.09 
106.44 
 
81.67 
 
71.03 
 
77.17 
 
62.15 
 
60.15 
 
53.35 
 
63.63 
 
54.18 
 
Although we feel that our overall study design was sound, there exist some limitations in 
our methods.  A retrospective cohort is cost effective and efficient in terms of collecting data, as 
all the variables of interest exist already, but it does leave potential for information bias.  By 
using such strict criteria for inclusion into the study, however, we attempted to limit the amount 
of information bias.  Despite the application of these criteria, however, it is still possible that 
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some of the infants analyzed were misclassified.  Specifically, in the 1995 cohort, PCR and other 
viral culturing methods were not as precise and developed as they are today.  But we feel that 
limiting the inclusion of infants with less than 100 WBC/mm3 limits the majority of potential 
viral meningitis cases.  Additionally, we assume that we have found all of the cases available 
during the time periods selected for analysis.  However, there still could be patients that we have 
missed.  Our findings are designed in a way to attempt to apply them to all infant populations 
less than 2 months of age. However, infants in other parts of the country may differ from those in 
Pittsburgh.   
 Another problem that exists in our study is the limited number of infants available for 
analysis in the 8-week age group.  In our entire study of 1,019 infants, only 36 were 8 weeks of 
age.  Because our sampling was done using only infants less than 60 days of age, our 8 week 
year old category was not complete.  This age range should have extended form 56-63 days, and 
thus infants ages 61-63 days were not included based on our less than 2 months of age criterion.  
This can explain why there is a discrepancy in the number of observations for this week category 
as compared to the others.  Additional reasons why this age in week category could be lower 
than the other week categories is that possible that at this age, parents are less likely to bring 
their infants to the emergency room for fever because they are more comfortable with the 
presence of a fever and are no longer concerned with the risks of meningitis. Another possible 
reason is that infants’ immune systems have matured enough at this point to prevent infection 
that could lead to meningitis. It is also possible that another reason exists which we have not 
considered. To examine these latter two explanations, it could be possible to see if the rates of 
infants ages 8 weeks of age is different for all visits to the emergency room, not just those that 
result in a lumbar puncture.  Also, parents of infants could be surveyed to see if their opinions on 
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whether or not they would be likely to bring their child in for examination following the onset of 
a fever for various age categories.  In the future, however, it might be possible to extend more 
infants 8 weeks of age by extending the cut-off from 60 to 63 days of age.  This would probably 
compensate for the variation seen in this study and make the age stratifications more uniform.  
 Further research can now be done to determine how effective these values are at the early 
identification of meningitis.  It is possible that another retrospective chart review could be 
beneficial to accomplish this goal.  By identifying cases of meningitis retrospectively, the CSF 
WBC, glucose, and protein values can be compared to those that were found upon initial CSF 
fluid examination.  By knowing how many infants with meningitis fall within our confidence 
intervals, we can get an idea of how accurate or inaccurate our values are for the application to 
“normal” infants.  If this retrospective study finds positive results indicating that these values are 
accurate predictors of bacterial and viral meningitis, it is possible to then introduce these values 
into practice to determine if they benefit physicians attempting to diagnose meningitis quickly 
and easily. The use of a prospective study would be valuable in analyzing these objectives.   
Regardless of the predictability of these values, however, it should be remembered that 
the CSF WBC, CSF glucose, and CSF protein are surrogate markers that can help identify the 
possibility of viral or bacterial meningitis, but they should not be used as a replacement for true 
diagnostic tests such as bacterial or viral culture or PCR.  These values are designed to aid in the 
decision making process of whether to start early treatment for bacterial or viral meningitis. 
 In conclusion, we have performed the largest retrospective cohort to date of normal 
infants to generate values for CSF components that may be useful in clinical practice for early 
identification of infants who would benefit from early treatment before diagnostic tests can be 
completed.  This study found that significant differences exist for CSF WBC and CSF protein for 
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infants of varying ages up to two months, but found no differences for CSF glucose.  This study 
proves that infants of varying ages should be stratified by week in age when determining what is 
“normal” for CSF components. 
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